Showing results (21-30 of 361) with videos related to
Sort By:
Pageof 37
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 11, 2003
Dialysis adequacy and response to erythropoietic agents: what is the evidence base?Francesco Locatelli, Lucia Del VecchioJournal of Nephrology|December 31, 2003
Pure red cell aplasia secondary to treatment with erythropoietinFrancesco Locatelli, Lucia Del VecchioThe Oncologist|September 21, 2011
Erythropoiesis-stimulating agents in renal medicineFrancesco Locatelli, Lucia Del VecchioExpert Opinion on Pharmacotherapy|November 29, 2013
Optimal phosphate control: still an unmet need in chronic kidney disease patientsFrancesco Locatelli, Lucia Del VecchioClinical Kidney Journal|September 9, 2020
Hypoxia response and acute lung and kidney injury: possible implications for therapy of COVID-19Lucia Del Vecchio, Francesco LocatelliCurrent Opinion in Nephrology and Hypertension|May 31, 2018
Will there still be a role for the originator erythropoiesis-simulating agents after the biosimilars and the hypoxia-inducible factor stabilizers approval?Francesco Locatelli, Lucia Del VecchioExpert Opinion on Drug Safety|August 25, 2012
Safety issues related to erythropoiesis-stimulating agents used to treat anemia in patients with chronic kidney diseaseLucia Del Vecchio, Francesco LocatelliNephron. Clinical Practice|September 5, 2009
Inhibition of the renin-angiotensin system in chronic kidney disease: a critical look to single and dual blockadeFrancesco Locatelli, Lucia Del Vecchio, Andrea CavalliJournal of Nephrology|December 6, 2007
Treating anemia at different stages of renal diseaseFrancesco Locatelli, Lucia Del Vecchio, Pietro PozzoniPeritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|November 22, 2007
Pure red-cell aplasia "epidemic"--mystery completely revealed?Francesco Locatelli, Lucia Del Vecchio, Pietro PozzoniPageof 37